Public Meeting: FDA Rare Disease Day 2026 02 23 2026 FDA Latest FDA Developments Shaping Clinical Trials in 20252026 EllieMD Dihexa DIHEXA Beverly Hills Rejuvenation Center DHX PNB 0408 Pure Health Peptides A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are